Key result
PAH pulmonary artery smooth muscle cells show ~2.2-fold higher ATP production under hypoxia vs. controls.
Why the study?
The metabolic state of pulmonary artery smooth muscle cells (PASMCs) from patients with pulmonary arterial hypertension (PAH) is not well understood.
Does hypoxia exposure alter ATP production pathways in pulmonary artery smooth muscle cells from patients with pulmonary arterial hypertension compared to non-PAH cells?
Does hypoxia exposure alter ATP production pathways in pulmonary artery smooth muscle cells from patients with pulmonary arterial hypertension compared to non-PAH cells?
PAH-PASMCs exhibit a unique metabolic shift, utilizing glycolysis under normoxia but preserving mitochondrial respiration under hypoxia, revealing potential novel therapeutic targets in energy metabolism for pulmonary arterial hypertension.
Answers are grounded in this paper and cite their sources.
Hypoxia-driven ATP differences in PAH cells should not alter practice; hypothesis-generating for metabolic targets pending in vivo validation.
BACKGROUND: The metabolic state of pulmonary artery smooth muscle cells (PASMCs) from patients with pulmonary arterial hypertension (PAH) is not well understood. In this study, we examined the balance between glycolysis and mitochondrial respiration in non-PAH-PASMCs and PAH-PASMCs under normoxia and hypoxia. METHODS: We investigated the enzymes involved in glycolysis and mitochondrial respiration, and studied the two major energy-yielding pathways (glycolysis and mitochondrial respiration) by measuring extracellular acidification rate (ECAR) and cellular oxygen consumption rate (OCR) using the Seahorse extracellular flux technology. RESULTS: Under both normoxia and hypoxia, the mRNA and protein levels of pyruvate dehydrogenase kinase 1 and pyruvate dehydrogenase were increased in PAH-PASMCs compared with non-PAH-PASMCs. The mRNA and protein levels of lactate dehydrogenase, as well as the intracellular lactate concentration, were also increased in PAH-PASMCs compared with non-PAH-PASMCs under normoxia. However, these were not significantly increased in PAH-PASMCs compared with non-PAH-PASMCs under hypoxia. Under normoxia, ATP production was significantly lower in PAH-PASMCs (59 ± 5 pmol/min) than in non-PAH-PASMCs (70 ± 10 pmol/min). On the other hand, ATP production was significantly higher in PAH-PASMCs (31 ± 5 pmol/min) than in non-PAH-PASMCs (14 ± 3 pmol/min) under hypoxia. CONCLUSIONS: There is an underlying change in the metabolic strategy to generate ATP production under the challenge of hypoxia.
No takes yet. Share an insight, caveat, or question.
Akagi et al. (2023) studied Pulmonary Arterial Hypertension (n=9). Hypoxia (2% O2) vs. Normoxia (20% O2) and non-PAH cells was evaluated on ATP production under hypoxia (p=<0.01). Under hypoxic conditions, pulmonary artery smooth muscle cells from patients with pulmonary arterial hypertension demonstrated higher ATP production compared to non-PAH controls.
Synapse has enriched 10 related papers. Consider them for comparative context: